重磅股推動恆科指數升幅擴至7.4% 京東集團/網易/明源雲/萬國數據急漲11%-20%
納指昨晚在fb、費城半導體指數及季績勝預期谷歌母企Alphabet依次升1.5%-3%支撐逆市回升0.7%。本港恆生科技指數繼昨天由紀錄低位反彈3.1%結束三連挫後，今早高開後，升幅持續擴至7.4%報6,921。
30只恆科成份股除海爾智家(06690.HK)及聯想集團(00992.HK)逆跌2.5%報25.45元及反覆逆穩外，全部造好，升幅普遍面超過4%-19%，萬國數據(09698.HK)升幅最大，股價由上市低位連升第二天，最高見61.15元，現報60.15元，飆19.6%。
獲大摩看45元料未來30天股價有七八成機率上升的明源雲(00909.HK)由逾一年低位連升第二天，最高見30.5元，現報30.3元，急漲近19%；網易(09999.HK)由逾一年低位連升兩天，最高見157.8元，現報157.6元，續升12%。
微盟(02013.HK)及遭大和降價至3.3元的新東方在線(01797.HK)由逾一年低位及上市低位連升第二天，最高見10.66元及4.9元，現報10.54元及4.8元，續升13%及15%。金山軟件(03888.HK)由逾一年低位連彈第二天高見36.35元，現報36.05元，續升13%。京東集團(09618.HK)由11個月低位連升兩個月兼重越10天線(278.5元)，最高見281.8元，現報278.6元，續升11%。嗶哩嗶哩(09626.HK)由上市新低連升兩天，最高見735.5元，現報714.5元，續升10%。
阿裏健康(00241.HK)由逾年半低位連升第二天，最高見12.14元，現報12.1元，急漲15%，爲最強藍籌；京東健康(06618.HK)由上市低位連升兩天，最高見84元，現報83.95，續升14%。平安好醫生(01833.HK)由近年半低位連升兩天，最高見75.95元，現報74.65元，續升7%。
重磅股騰訊(00700.HK)承昨天收復逾半成失地由逾一年低位422元倒升勢，今早高見487.8元，現報487.2元，續升8.9%；美團(03690.HK)由近一年低位兩連升，最高見231.4元，現報227.6元，急升9.1%；阿裏巴巴(09988.HK)由近年半低位續彈6.5%報195.2元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
